On the other side, M-MDSCs, lower producers of ARG1 in HNSCC settings, did not affect patient prognosis or response, demonstrating that M-MDSCs may not be a prognostic marker in solid tumors [61]. This evidence concerns the gene ARG1 and head and neck squamous cell carcinoma.